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Background: Open abdomen treatment (OAT) is considered a lifesaving procedure in patients with abdominal compart-
ment syndrome (ACS) after endovascular or open intervention for ruptured abdominal aortic aneurysms (RAAA).
Standardized treatment methods and algorithms for its use are still lacking. The high, published mortality rates may
reflect difficulties in detecting and treating ACS, especially in patients treated by emergency endovascular aneurysm repair
(eEVAR). Presented are standardized algorithms for OAT, including a new technique using the vacuum-assisted closure
(VAC) system developed during 10 years of experience with eEVAR for RAAA.
Methods: We retrospectively analyzed 102 patients with RAAA treated by eEVAR from January 1998 to April 2008.
Abdominal decompression was done when intravesical pressure >20 mmHg or when abdominal perfusion pressure was
<50 to 60 mmHg and concomitant organ deterioration occurred. OATwas initially done with a subcutaneously sutured
plastic bag or with a nonsutured zipper drape combined with a VAC device (VAC/ETHIZIP; KCI International Inc,
Amstelveen, The Netherlands; Ethicon, Somerville, NJ). All patients were switched to VAC/ETHIZIP as soon as
possible. Dressings were generally changed every 3 to 5 days. Intra-abdominal pressure was monitored until stability was
observed after delayed direct abdominal closure.
Results:Overall 30-day mortality for eEVAR was 13% (13 of 102); 8% (7 of 82) for patients without ACS and 30% (6 of
20) for those with ACS. Decompression for ACS was needed in 20 patients (20%) primarily during the intervention (n
14) or secondarily in the intensive care unit (n  6). Six of 20 (30%) patients requiring OAT died <30 days (4 primary,
2 secondary). A mean of 3.6 (range, 1-12) planned second-look interventions were done per patient at an interval of 3 to
5 days. No bowel lesions were observed. Four patients required antibiotic therapy for abdominal infection, and all
infections resolved. Delayed abdominal wall closure (direct closure, 11; closure with polypropylene mesh, 3; bilateral
anterior rectus abdominis sheath turnover flap, 1) was achieved after a median of 6 days (range, 1-47 days).
Conclusion: The use of standardized novel techniques and a treatment protocol and algorithm for OAT after eEVAR for
RAAA were feasible and safe. It decreased the workload of the medical and nursing staff, enhanced patient comfort
because the need for dressing changes was minimized, and likely contributed to lower overall mortality in RAAA patients.
Delayed direct fascial closure was possible in most patients. ( J Vasc Surg 2009;50:1-7.)Open abdomen treatment (OAT) is considered a lifesav-
ing procedure in patients with abdominal compartment syn-
drome (ACS) after endovascular or open intervention for
ruptured abdominal aortic aneurysms (RAAA).1-9 Since its
first description by Fietsam2 in this patient cohort, many
technical reports have been published. Clear treatment algo-
rithms are still lacking, however, and the high mortality rates
published10 may reflect difficulties in detecting and treating
ACS.5 This is especially true for patients treated by emergency
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doi:10.1016/j.jvs.2008.12.030endovascular aneurysm repair (eEVAR) who do not undergo
a laparotomy as part of their primary procedure.11-14
This study reports our 10-year experience with the
management of patients requiring OAT after eEVAR for
RAAA. A further objective is to provide an algorithm for
the diagnosis of intra-abdominal hypertension and abdom-
inal compartment syndrome (ACS) and to demonstrate a
standardized method for performing OAT.
METHODS
Patients. From January 1998 to April 2008, 102 of
212 consecutive patients with RAAA were treated by
eEVAR in our tertiary referral center. Patients were a mean
age of 73  9 years (range, 48-90 years). Aneurysm rup-
ture, defined as blood outside the aortic wall, was con-
firmed by computed tomography angiography in all pa-
tients. Blood was present in the retroperitoneum in 64, in
the peritoneal cavity in 33, and in the duodenum (aor-
toduodenal fistula) in five. Critical clinical data were pro-
spectively collected and retrospectively analyzed. A system-
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initiated for details concerning ACS. The Institutional Re-
view Board approved the study.
Patient monitoring. For all patients with RAAA—but
in particular for patients treated by eEVAR—a proactive
approach to the detection and treatment of intra-abdominal
hypertension (IAH) is critical. These patients are at high
risk for development of ACS and therefore, close monitor-
ing of intravesical pressure (IVP; corresponds to intra-
abdominal pressure) and organ function is crucial to detect
critical IAH. The IVP measurement was initiated during
EVAR and repeated every hour after the procedure (see
Open abdomen treatment).
Urinary output, respiratory function and indices for
bowel ischemia (blood lactate and lactate dehydrogenase
elevation) were closely monitored. Close surveillance of
IVP and organ function was continued in all patients either
with or without abdominal decompression for the duration
of IAH. Importantly, this surveillance was continued dur-
ing the whole course of stepwise approximation of the
fascial borders and subsequent fascial closure after abdom-
inal decompression.
Open abdomen treatment. Abdominal decompres-
sion after eEVARwas done during the primary intervention
or secondarily in the intensive care unit (ICU). Indication
for surgical decompression was based on an IVP 20 mm
Hg or abdominal perfusion pressure (systemic mean pres-
sure minus intra-abdominal pressure) of 50 to 60 mm
Hg and new development of organ dysfunction, or when
patients fulfilled at least one of the criteria from the
Table.9,15-17
The general algorithm of OAT for all RAAA patients in
our institution is illustrated in Fig 1. To avoid IAH, the
abdomen is primarily left open in all open repairs for RAAA.
Patients treated by eEVAR are at high risk for develop-
ment of ACS; therefore, close monitoring of IVP and organ
function is crucial to detect critical IAH. IVP measurement
is initiated during EVAR and repeated every hour after the
procedure. Intermittent IVP measurement3,18 is accom-
plished with a standard Foley catheter and volume priming
with 25 mL of normal saline in the supine position during
end expiration. The midaxillary line serves as the zero
reference point. Urinary output, respiratory function, and
indices for bowel ischemia (lactate and lactose dehydroge-
Table. Predisposing factors for abdominal compartment
syndromea
● Deep shock
Systolic blood pressure  70 mm Hg during 20 minutes
 Hemoglobin  8 g/dL
 pH  7.3
● Intraoperative fluid infusion  5 L
● Transfusion  6 U red blood cell concentrates
● Temperature grade  35°C
● Vast retroperitoneal hematoma
● Massive bowel swelling
aModified from references 9, 15-17.nase elevation) are closely monitored.Surgical decompression is initiated when critical IAH is
present and new organ dysfunction develops or when patients
fulfill at least one of the criteria presented in the Table. In
stable patients, surveillance is continued as mentioned.
The algorithm to choose the optimal type of OAT is
illustrated in Fig 2. Once the decision for OAT is made,
decompressive laparotomy is performed urgently. Subject
to the clinical findings in the abdomen, two different path-
ways are possible: temporary closure with (1) a plastic bag
silo closure (Bogota bag)19 and conventional secondary
dressing, or (2) a vacuum-assisted closure (VAC) system
(V.A.C., KCI International Inc, Amstelveen, The Nether-
lands). Key indicators for this decision are the volume of the
intra-abdominal organs protruding from the abdomen due
to massive swelling (Fig 3) and suspicion of impending
bowel necrosis due to prolonged ischemia from hypoten-
sion, compression, and elevated IVP. If these factors are
present, the abdomen is temporarily closed with a simple,
large, sterile plastic drape or bag, which makes direct visu-
alization of the small bowel possible (Fig 3). A bag silo
closure also provides a large reserve capacity allowing
further intra-abdominal organ swelling without relevant
IVP elevation, thus preventing recurrent increased intra-
abdominal pressure in the initial phase after decompression
of ACS compared with other temporary abdominal closure
techniques.20
The technique recently has been modified to improve
the management of excessive fluid loss from the bag silo,
still keeping its large reserve capacity (Bogota-VAC, Fig
4).21 For minor bowel edema/distension, a VAC system is
placed over a zipper drape (Fig 5; ETHIZIP, Ethicon Inc,
Somerville, NJ). This technique, which we call VAC-over-
ETHIZIP (VAC/ETHIZIP), is described in detail in the
next section.
When the bag silo is initially applied, a second-look
intervention with inspection of the abdominal contents is
always performed 1 to 2 days after abdominal decompres-
sion. Temporary abdominal closure is converted to the
VAC/ETHIZIP technique when (1) the patient is stabi-
lized, (2) IVP remains15 mmHg, or (3) organ function
is improved. In the situation of continued or even deterio-
rated ACS, the bag silo is applied again.
Our algorithm specifies that stable patients with pri-
mary application of the VAC/ETHIZIP undergo second-
look interventions every 3 to 5 days with stepwise approx-
imation of the fascial borders. The underlying zipper drape
and the VAC foam are narrowed accordingly. In the situa-
tion of recurrent ACS during the latter course, however,
the abdomen is decompressed again with the bag silo
closure. The technique is converted back to VAC/
ETHIZIP with continued fascial approximation whenever
suitable until definitive closure.
VAC/ETHIZIP Technique. The abdomen is left
open after laparotomy and the zipper drape is placed su-
tureless underneath the entire abdominal wall (Fig 5). The
VAC (black polyurethane foam) is then applied over the
ETHIZIP and a subatmospheric pressure of 50 mm Hg is
initiated (Fig 6). The zipper drape is reused after second-
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closure is considered when the abdominal wall can be
partially or totally approximated without any increase of the
IVP. For this purpose, the ETHIZIP is shaped so that the
wound area covered will be smaller and smaller. Accord-
ingly, the size of the VAC foam is also reduced to allow for
a stepwise fascial approximation and then reapplied. De-
layed direct fascial (running suture with size 0Maxon loop,
Fig 1. General algorithm for open abdomen treatment
ruptured abdominal aortic aneurysm (RAAA). ACS, Ab
*For risks, see the Table.TycoHealthcare, Mansfield, Mass) and skin closure is donewhen the abdomen is clinically tension free and the fascial
borders can be completely approximated without any in-
crease in bladder pressure. In case of prolonged OAT due
to abdominal inflammation or infection, direct closure of
the abdominal fascia may prove impossible. Permanent
closure may then be achieved by the bilateral anterior rectus
abdominis sheath turnover flap method described by
Kushimoto et al.22 The skin is then mobilized from the
emergency endovascular aneurysm repair (EVAR) for
inal compartment syndrome; ICU, intensive care unit.after
domfascia and primarily approximated.
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Overall 30-day mortality for eEVAR was 13% (13 of
Fig 2. Algorithm to choose the optimal type of open
aneurysm repair (eEVAR) for ruptured abdominal a
VAC/ETHIZIP, VAC-over-ETHIZIP.
Fig 3. Temporary abdominal closure with a simple, large sterile
plastic drape or bag allows direct visualization of the bowel and
further swelling of the abdomen without pressure rise.102). Reasons for death were suicide in 1, multiorganfailure in 5, cardiac events in 3, bleeding in 3, and bowel
ischemia in 1. The 30-day mortality was 8% (7 of 82) for
patients without ACS and 30% (6 of 20) for those with
ACS.
Decompression after eEVAR for ACS was required in
20 patients (20%), either during the intervention (n  14)
or later in the ICU (n  6). Six of 20 (30%) patients
requiring OAT died 30 days. The two groups had a
similar mortality rate (OAT during intervention, 4 of 14
patients; OAT later in the ICU, 2 of 6). One patient died in
the operating room due to uncontrollable intraoperative
decompressive bleeding, 1 died of multiorgan failure after
small bowel ischemia, 1 died of sepsis after ischemic chole-
cystitis, 2 died of cardiac events, and 1 died pneumonia 29
days after the intervention.
Five of the remaining 14 OAT patients needed a tem-
porary abdominal closure with a plastic drape or bag due to
massive volume increase of the abdominal contents or
suspicion of imminent bowel necrosis. In the other nine
patients, VAC/ETHIZIP was initiated primarily. A mean
of 3.6 (range, 1-12) planned second-look interventions
were done per patient with an interval of 3 to 5 days. No
omen treatment (OAT) after emergency endovascular
aneurysm (RAAA). VAC, Vacuum assisted closure;abd
orticbowel lesions or fistulas were observed during OAT. Local
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patients, and four patients required antibiotic therapy for
abdominal infection. All infections resolved under antibi-
otic therapy.
Delayed closure of the abdominal wall was achieved
after a median of 6 days (range 1-47 days). Direct fascial
closure was possible in 11 patients. Of the remaining three
patients, two received a polypropylene mesh and one un-
derwent a bilateral anterior rectus abdominis sheath turn-
over flap and direct skin closure.
DISCUSSION
ACS is a major cause of death after endovascular and
Fig 4. A ring shaped black polyurethane foam of the vacuum-
assisted closure system is put near the border where the Bogota bag
is sutured to the skin. The adhesive foils just cover the polyure-
thane foam, not the whole bag silo. The TRAC-PAD (KCI Inter-
national Inc, Amstelveen, The Netherlands) of the vacuum-
assisted closure system is positioned so that it doesn’t interfere with
the bag or skin.
Fig 5. Zipper drape placed sutureless underneath the entire ab-
dominal wall.open repair for RAAA.2,7,9,23-27 ACS-related mortalityrates published for open repair are generally 50% and up
to 100%. In a 2005 article, Mehta et al6 report a 57%
mortality rate for patients with ACS after eEVAR for
RAAA. Detection and treatment of ACS are therefore
considered lifesaving and mandatory.9,24 Vigilant aware-
ness for ACS and consequent treatment according to our
standard protocol has resulted in a low 30-day mortality of
13% in our patient cohort of 102 RAAAs treated endovas-
cularly during a 10-year period.
Prevalence of ACS was much higher in our study than
reported in the current literature after eEVAR.11-14 De-
spite this high prevalence of ACS, the mortality was con-
siderably lower in our eEVAR patients. We speculate that
the difference in the prevalence of ACS and the short-term
mortality might in part reflect an underdiagnosis or under-
treatment of ACS in many previous studies. Notwithstand-
ing the early diagnosis and aggressive management of ACS,
the OAT subgroup had a 30% mortality. However, there
was no difference in mortality in our study between the two
groups of primary (intraoperative) OAT and secondary
(later in the ICU) OAT, because decompression laparot-
omy was done in all cases before organ failure occurred.
This meticulous surveillance and aggressive management of
IAH might explain the difference with the published data
from Rasmussen et al9 that show a tendency of increased
in-hospital mortality in patients with late decompression
after development of ACS.9 However, the data are difficult
to compare due to the different management of both
groups (endovascular vs open repair). Furthermore, to
date, the best timing of abdominal decompression is still
unknown and should be investigated further.
A variety of therapeutic modalities for OAT have been
published during the last 20 years.23,24,28-36 Although
algorithms have been proposed for the management of
IAH and abdominal compartment syndrome after open
RAAA repair, none have been proposed in the setting of
eEVAR. In this article, we provide simple, safe clinical
Fig 6. Polyurethane foam applied over the ETHIZIP with suc-
tion of 50 to 100 mm Hg.decision trees for OAT after successful endovascular sealing
JOURNAL OF VASCULAR SURGERY
July 20096 Mayer et alof RAAA as well as for choosing the optimal type of OAT
according to the clinical presentation during the initial
intervention or a secondary procedure. Key indicators are
provided to help to initiate the best treatment available.
Bowel ischemia can be easily and rapidly detected
through the transparent plastic drape or bag fixed only
loosely to the skin. Furthermore, room is provided for
further volume increases in the abdominal contents.20 Our
VAC/ETHIZIP technique represents a simple and clean
dressing that has to be changed every 3 to 5 days, thus
providing more comfort to the patient and less workload
for the ICU or ward staffs. The abdominal fascia is not
traumatized, because neither the zipper drape nor the foam
is fixed by sutures. Delayed step-wise wound closure can be
accomplished with clean and healthy fascial margins, en-
hancing the probability of uneventful closure without her-
nia formation.
Finally, topical negative-pressure VAC dressing tech-
niques have several benefits. This method exerts antimicro-
bial activity37 and stimulates granulation tissue forma-
tion.38,39 By its mechanical mode of action,40 the VAC
probably stabilizes the abdominal wall and may prevent
abdominal wall retraction. VAC/ETHIZIP has been pre-
ferred rather than the prefabricated abdominal VAC system
for three reasons:
1. better protection of the intra-abdominal contents when
using the ETHIZIP compared with the thin and porous
plastic foil, potentially decreasing the risk of abdominal
fistulae,
2. better and safer patient mobilization due to a thicker
and therefore more stable standard polyurethane foam
compared with the prefabricated abdominal VAC foam,
possibly leading to fewer eventrations due to VAC fail-
ures, and
3. lower cost of VAC/ETHIZIP compared with the com-
mercially available dressing.
This study has several limitations. The first is the ab-
sence of a control group (conservative treatment) that
would allow proving and quantifying the effect of the OAT
treatment in RAAA patients treated by EVAR. With the
acquired knowledge about the negative effect of untreated
ACS in RAAA patients managed by open repair in the past
years, however, we believe it is unethical to randomize
patients to an control group and then not treat them.
Furthermore, the recent publication of Mehta et al6 sup-
ports the aggressive diagnostic approach and treatment of
ACS by OAT in RAAA patients managed by eEVAR.
A second limitation is the lack of a comparative group
with a different treatment modality or algorithm. Thus, our
study cannot answer the question of whether there exists
another possibly more effective approach to ACS in RAAA
patients treated by eEVAR. We believe, however, that the
30-day mortality of 13% obtained in our study with 102
RAAA patients managed by eEVAR has proven the effec-
tiveness of our algorithm. Furthermore, although relatively
frequent, the total number of patients per year with ACS
after eEVAR is relatively low, and the experience wouldhave been diluted by following too many combinations of
algorithms and treatment choices.
A third limitation is the lack of comparison of RAAA
patients treated by eEVARwith open repair. Our algorithm
precludes such a comparison because we primarily use OAT
in all patients managed by open repair. We are not able,
therefore, to provide evidence of the effectiveness of our
general algorithm including all RAAA patients.
Finally, although there is growing evidence of the
mechanism of action of wounds managed with VAC, our
study cannot definitely prove the assumptions made about
the beneficial action of such therapy. Further studies
should, therefore, include and quantify parameters such as
antimicrobial activity, granulation tissue formation, and
mechanical stability of the abdominal wall treated by VAC/
ETIZIP.
CONCLUSION
The use of standardized novel techniques along with a
treatment protocol and algorithm for OAT after eEVAR
for RAAA proved to be feasible and safe. The workload of
the medical and nursing staff was decreased and patient
comfort was enhanced because the need for dressing
changes was minimized. We believe it also contributed to
lower overall mortality in RAAA patients. Delayed direct
fascial closure was possible in most patients. Widespread
use of these systems, methods, and algorithms is recom-
mended.
AUTHOR CONTRIBUTIONS
Conception and design: DM, ML
Analysis and interpretation: DM, ZR, CM, FV
Data collection: DM, ZR
Writing the article: DM, CM, FV, ML
Critical revision of the article: DM, ZR, CM, TP, FV, ML
Final approval of the article: DM, ZR, CM, TP, FV, ML
Statistical analysis: DM (descriptive statistics)
Obtained funding: Not applicable
Overall responsibility: DM
REFERENCES
1. Djavani K, Wanhainen A, Bjorck M. Intra-abdominal hypertension and
abdominal compartment syndrome following surgery for ruptured ab-
dominal aortic aneurysm. Eur J Vasc Endovasc Surg 2006;6:581-4.
2. Fietsam R Jr, Villalba M, Glover JL, Clark K. Intra-abdominal compart-
ment syndrome as a complication of ruptured abdominal aortic aneu-
rysm repair. Am Surg 1989;6:396-402.
3. Kron IL, Harman PK, Nolan SP. The measurement of intra-abdominal
pressure as a criterion for abdominal re-exploration. Ann Surg 1984;1:
28-30.
4. Lachat M, Mayer D, Labler L, Schnell A, Modaressi K, Genoni M, et al.
Abdominal compartment syndrome following ruptured AAA. Contro-
versies and updates in vascular surgery. Torino, Italy: Edizioni Minerva
Medica; 2006. p. 103-7.
5. Mayer D, Pfammatter T, Gauer JM, WilhelmM, Labler L, Weber D, et
al. Abdominal compartment syndrome after ruptured abdominal aortic
aneurysm. J Vasc Endovasc Surg (Italian) 2006:73-6.
6. Mehta M, Darling RC 2nd, Roddy SP, Fecteau S, Ozsvath KJ, Kreien-
berg PB, et al. Factors associated with abdominal compartment syn-
drome complicating endovascular repair of ruptured abdominal aortic
aneurysms. J Vasc Surg 2005;6:1047-51.
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 1 Mayer et al 77. Oelschlager BK, Boyle EM Jr, Johansen K, Meissner MH. Delayed
abdominal closure in the management of ruptured abdominal aortic
aneurysms. Am J Surg 1997;5:411-5.
8. Papavassiliou V, Anderton M, Loftus IM, Turner DA, Naylor AR,
London NJ, et al. The physiological effects of elevated intra-abdominal
pressure following aneurysm repair. Eur J Vasc Endovasc Surg 2003;3:
293-8.
9. Rasmussen TE, Hallett JW Jr, Noel AA, Jenkins G, Bower TC, Cherry
KJ Jr, et al. Early abdominal closure with mesh reduces multiple organ
failure after ruptured abdominal aortic aneurysm repair: guidelines from
a 10-year case-control study. J Vasc Surg 2002;2:246-53.
10. BownMJ, Sutton AJ, Bell PR, Sayers RD. Ameta-analysis of 50 years of
ruptured abdominal aortic aneurysm repair. Br. J Surg 2002;6:714-30.
11. Acosta S, Lindblad B, Zdanowski Z. Predictors for outcome after open
and endovascular repair of ruptured abdominal aortic aneurysms. Eur J
Vasc Endovasc Surg 2007;3:277-84.
12. Greco G, Egorova N, Anderson PL, Gelijns A, Moskowitz A, Now-
ygrod R, et al. Outcomes of endovascular treatment of ruptured ab-
dominal aortic aneurysms. J Vasc Surg 2006;3:453-9.
13. Hinchliffe RJ, Bruijstens L, MacSweeney ST, Braithwaite BD. A ran-
domised trial of endovascular and open surgery for ruptured abdominal
aortic aneurysm - results of a pilot study and lessons learned for future
studies. Eur J Vasc Endovasc Surg 2006;5:506-13; discussion 514-5.
14. Peppelenbosch N, Geelkerken RH, Soong C, Cao P, Steinmetz OK,
Teijink JA, et al. Endograft treatment of ruptured abdominal aortic
aneurysms using the Talent aortouniiliac system: an international mul-
ticenter study. J Vasc Surg 2006;6:1111-23.
15. Levison JA, Halpern VJ, Kline RG, Faust GR, Cohen JR. Perioperative
predictors of colonic ischemia after ruptured abdominal aortic aneu-
rysm. J Vasc Surg 1999;1:40-5; discussion 45-7.
16. McNelis J, Marini CP, Jurkiewicz A, Fields S, Caplin D, Stein D, et al.
Predictive factors associated with the development of abdominal com-
partment syndrome in the surgical intensive care unit. Arch Surg
2002;2:133-6.
17. McNelis J, Marini CP, Simms HH. Abdominal compartment syn-
drome: clinical manifestations and predictive factors. Curr Opin Crit
Care 2003;2:133-6.
18. Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De
Waele J, et al. Results from the International Conference of Experts on
Intra-abdominal Hypertension and Abdominal Compartment Syn-
drome. I. Definitions. Intensive Care Med 2006;11:1722-32.
19. Fernandez L, Norwood S, Roettger R, Wilkins HE 3rd. Temporary
intravenous bag silo closure in severe abdominal trauma. J Trauma
1996;2:258-60.
20. Benninger E, Labler L, Seifert B, Trentz O, Menger MD, Meier C. In
vitro comparison of intra-abdominal hypertension development after
different temporary abdominal closure techniques. J Surg Res 2008;1:
102-6.
21. von Rüden C, Benninger E, Mayer D, Trentz O, Labler L. Bogota-
VAC—a newly modified temporary abdominal closure technique. Eur
J Trauma Emerg Surg 2008 (online at http://www.springerlink.com/
content/u3086w0072w4tg06/.)
22. Kushimoto S, Yamamoto Y, Aiboshi J, Ogawa F, Koido Y, Yoshida R, et
al. Usefulness of the bilateral anterior rectus abdominis sheath turnoverflap method for early fascial closure in patients requiring open
abdominal management. World J Surg 2007;1:2-8; discussion 9-10.
23. Ciresi DL, Cali RF, Senagore AJ. Abdominal closure using nonabsorb-
able mesh after massive resuscitation prevents abdominal compartment
syndrome and gastrointestinal fistula. Am Surg 1999;8:720-4.
24. Loftus IM, Thompson MM. The abdominal compartment syndrome
following aortic surgery. Eur J Vasc Endovasc Surg 2003;2:97-109.
25. Loi P, De Backer D, Vincent JL. Abdominal compartment syndrome.
Acta Chir Belg 2001;2:59-64.
26. McNelis J, Soffer S, Marini CP, Jurkiewicz A, Ritter G, Simms HH, et
al. Abdominal compartment syndrome in the surgical intensive care
unit. Am Surg 2002;1:18-23.
27. Nathens AB, Brenneman FD, Boulanger BR. The abdominal compart-
ment syndrome. Can J Surg 1997;4:254-8.
28. Barker DE, Kaufman HJ, Smith LA, Ciraulo DL, Richart CL, Burns
RP. Vacuum pack technique of temporary abdominal closure: a 7-year
experience with 112 patients. J Trauma, 2000;2:201-6.
29. Fox VJ, Miller J, Nix AM. Temporary abdominal closure using an i.v.
bag silo for severe trauma. AORN J 1999;3:530-41.
30. Foy HM, Nathens AB, Maser B, Mathur S, Jurkovich GJ. Reinforced
silicone elastomer sheeting, an improved method of temporary abdom-
inal closure in damage control laparotomy. Am J Surg 2003;5:498-501.
31. Kafie FE, Tessier DJ, Williams RA, Podnos YD, Cinat M, Lekawa M, et
al. Serial abdominal closure technique (the “SAC” procedure): a novel
method for delayed closure of the abdominal wall. Am Surg 2003;2:
102-5.
32. Navsaria PH, Bunting M, Omoshoro-Jones J, Nicol AJ, Kahn D.
Temporary closure of open abdominal wounds by the modified sandwich-
vacuum pack technique. Br J Surg 2003;6:718-22.
33. Sherck J, Seiver A, Shatney C, Oakes D, Cobb L. Covering the “open
abdomen”: a better technique. Am Surg 1998;9:854-7.
34. Tobias AM, LowDW. The use of a subfascial vicryl mesh buttress to aid
in the closure of massive ventral hernias following damage-control
laparotomy. Plast Reconstr Surg 2003;3:766-76.
35. Tremblay LN, Feliciano DV, Schmidt J, Cava RA, Tchorz KM, Ingram
WL, et al. Skin only or silo closure in the critically ill patient with an
open abdomen. Am J Surg 2001;6:670-5.
36. Petersson U, Acosta S, Bj·orck M. Vacuum-assisted wound closure and
mesh-mediated fascial traction—a novel technique for late closure of
the open abdomen. World J Surg 2007;31:2133-7.
37. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-
assisted closure: a newmethod for wound control and treatment: animal
studies and basic foundation. Ann Plast Surg 1997;6:553-62.
38. Moisidis E, Heath T, Boorer C, Ho K, Deva AK. A prospective,
blinded, randomized, controlled clinical trial of topical negative pres-
sure use in skin grafting. Plast Reconstr Surg 2004;4:917-22.
39. Morykwas MJ, Faler BJ, Pearce DJ, Argenta LC. Effects of varying
levels of subatmospheric pressure on the rate of granulation tissue
formation in experimental wounds in swine. Ann Plast Surg 2001;5:
547-51.
40. Isago T, Nozaki M, Kikuchi Y, Honda T, Nakazawa H. Effects of
different negative pressures on reduction of wounds in negative pressure
dressings. J Dermatol 2003;8:596-601.Submitted Oct 19, 2008; accepted Dec 16, 2008.
